Search results for “Enzyme inhibitor” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 30,932 patents, we discovered top 473 key players by total patent application. Novartis AG, Merck & Co., Inc., F. Hoffmann-La Roche Ltd. are dominant in this area. They take 8.28% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 1,064
New Jersey, United States
Patent: 806
Switzerland
Patent: 692
Massachusetts, United States
Patent: 655
Jiangsu Sheng, China
Patent: 582
Pennsylvania, United States
Patent: 578
New York, United States
Patent: 569
New York, United States
Patent: 447
New Jersey, United States
Patent: 428
Antwerpen, Belgium
Patent: 404
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 259 patents, we discovered top 52 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, SyntheX, Inc., NiKang Therapeutics, Inc. are active in this area.
STARTUP
France
Patent: 45
STARTUP
California, United States
Patent: 34
STARTUP
Delaware, United States
Patent: 21
STARTUP
Bayern, Germany
Patent: 9
STARTUP
Baden-Württemberg, Germany
Patent: 9
STARTUP
France
Patent: 8
STARTUP
North Carolina, United States
Patent: 7
STARTUP
Buckinghamshire, United Kingdom
Patent: 7
STARTUP
California, United States
Patent: 7
STARTUP
New Jersey, United States
Patent: 6
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 3,063 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Array BioPharma, Inc., BASF AB, Jiangsu Hengrui Pharmaceuticals Co., Ltd. take 4.28% of patent filing during this period.
Colorado, United States
Patent: 46
Sweden
Patent: 43
Jiangsu Sheng, China
Patent: 42
California, United States
Patent: 41
Switzerland
Patent: 40
United Kingdom
Patent: 35
Delaware, United States
Patent: 35
Porto, Portugal
Patent: 34
Shanghai Shi, China
Patent: 27
Missouri, United States
Patent: 23
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 3,063 patents in last 5 years, we discover 202 new entrants. NiKang Therapeutics, Inc., Suzhou Suncadia Biopharmaceuticals Co., Ltd., Zhuhai Yufan Biotechnologies Co., Ltd are the most active new entrants in this area.
STARTUP
Delaware, United States
Patent: 21
Jiangsu Sheng, China
Patent: 17
China
Patent: 16
British Columbia, Canada
Patent: 11
Basel-Stadt, Switzerland
Patent: 10
Zhejiang Sheng, China
Patent: 9
Jiangxi Sheng, China
Patent: 9
Taigen Pharmaceutical R & D (Beijing) Co Ltd
Beijing Shi, China
Patent: 9
STARTUP
Bayern, Germany
Patent: 9
Crystal Pharmaceutical (Suzhou) Co., Ltd
Jiangsu Sheng, China
Patent: 8
Research Institutions
Order by:
Innovation Intensity
With the analysis among 3,793 patents, we discovered top 280 universities and scientific research institutions by total patent application. Shanghai Institute of Materia Medica Chinese Academy of Sciences, University of Miami, The Johns Hopkins University are dominant in this area. They take 7.59% of the total patent filing.
Shanghai Shi, China
Patent: 91
United States
Patent: 48
United States
Patent: 44
Jiangsu Sheng, China
Patent: 43
California, United States
Patent: 38
North Carolina, United States
Patent: 34
Georgia, United States
Patent: 34
Massachusetts, United States
Patent: 28
New York, United States
Patent: 27
Jilin Sheng, China
Patent: 27
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: